Search - tctmd.com

Displaying 421 - 440 of 999

Sort: Relevancy | Date

Potential Warning Signs Seen for NOAC Use After TAVR

News Daily News

Potential Warning Signs Seen for NOAC Use After TAVR

June 12, 2019

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

News Daily News

TAVR in End-stage Renal Disease: Increased Risk Highlights Research Gaps

Yael L. Maxwell

June 11, 2019

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

June 07, 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

News Conference News SCAI 2019

TAVR Operators: Can One Do It All or Are Two Still Justified?

Yael L. Maxwell

June 04, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

May 23, 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

News Conference News EuroPCR 2019

Valve Leaflet Scoring Device for Aortic Stenosis Clears Feasibility Hurdle

Michael O'Riordan

May 23, 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

News Conference News EuroPCR 2019

Longer Follow-up ‘Reassuring’ for New-Onset LBBB After TAVR—With Caveats

Michael O'Riordan

May 22, 2019

News Industry News

BioTrace Medical’s Tempo Lead Obtains CE Mark for Safe and Secure Temporary Intracardiac Pacing

May 08, 2019

News Industry News

Pi-Cardia Successfully Completes First-in-Human Studies with Novel Non-implant Based Treatment of Aortic Stenosis

May 07, 2019

Episode 3: Low Risk Trials

Podcast Taking It To Heart

Episode 3: Low Risk Trials

May 06, 2019

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

News Daily News

Public Comments Largely Supportive of CMS Plan for TAVR, With Some Suggested Tweaks

May 01, 2019

Women Have Higher Risk of TAVR-Related Pericardial Complications

News Daily News

Women Have Higher Risk of TAVR-Related Pericardial Complications

April 26, 2019

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

April 16, 2019

Latest Observational Data Support TAVR Durability Through 7 Years

News Daily News

Latest Observational Data Support TAVR Durability Through 7 Years

April 12, 2019

Management of CAD and Aortic Stenosis: Current Thought on the Low Risk Patient

Presentation ARCH 2019

Management of CAD and Aortic Stenosis: Current Thought on the Low Risk Patient

Presenter: Marc A. Sintek

April 11, 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

News Conference News ACC 2019

My Takeaways From ACC 2019: Breaking With Embargoes? Despite the Drama, Embargoes Set to Stay

April 05, 2019

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

News Daily News

Volume Still an Important Surrogate for TAVR Quality, New Data Suggest

April 03, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.